T1 Gene 1129 1148 over-expressed EGFR
T2 Protein 710 712 s 
T3 Biomarker 724 737 more-specific
T4 Protein 276 278 s 
T5 Protein 678 692 membrane prote
T6 Condition 226 236 malignancy
T7 Protein 865 876 molecularly
T8 Protein 262 266 EGFR
T9 Protein 1426 1428 s 
T10 Protein 452 454 s 
T11 Gene 503 513 antibodies
T12 Protein 1030 1048 doxorubicin-loaded
T13 Level 1118 1123 cells
T14 Protein 543 545 s 
T15 Condition 313 320 cancers
T16 Protein 619 621 s 
T17 Level 698 711  cancer cells
T19 Biomarker 1030 1041 doxorubicin
T20 Protein 1462 1479 membrane proteins
T21 Condition 151 158 cancers
T22 Condition 128 158 triple-negative breast cancers
T23 Protein 910 918 nanoMIPs
T24 Protein 517 541 target membrane proteins
T25 Protein 512 514 s 
T26 Protein 1304 1306 s 
T27 Protein 1376 1378 s 
T28 Protein 1460 1462 s 
T29 Protein 70 72 s 
T30 Protein 540 542 s 
T31 Protein 1066 1068 s 
T32 Gene 257 277 anti-EGFR antibodies
T33 Protein 319 321 s 
T34 Protein 1240 1242 s 
T35 Protein 596 598 s 
T36 Protein 887 894 polymer
T37 Protein 1298 1300 s 
T38 Gene 1222 1232 antibodies
T39 Protein 1231 1233 s 
T40 Protein 1317 1319 s 
T42 Condition 95 101 tumors
T43 Protein 524 538 membrane prote
T44 Protein 1452 1454 s 
T45 Protein 418 420 s 
T47 Protein 678 695 membrane proteins
T48 Protein 327 329 s 
T49 Gene 985 992 epitope
T50 Level 706 710 cell
T51 Protein 1462 1476 membrane prote
T53 Protein 34 38 EGFR
T54 Protein 1102 1104 s 
T56 Protein 1159 1161 s 
T57 Protein 1054 1058 EGFR
T58 Biomarker 944 955 doxorubicin
T59 Protein 1059 1067 nanoMIPs
T60 Level 1409 1413 cell
T61 Level 1118 1122 cell
T62 Protein 1369 1377 nanoMIPs
T63 Protein 694 696 s 
T64 Protein 1122 1124 s 
T65 Protein 907 909 s 
T66 Protein 996 1000 EGFR
T67 Biomarker 43 67 tyrosine kinase receptor
